1. CeO2-azacrown conjugate as a nanoplatform for combined radiopharmaceuticals
- Author
-
Khabirova, S. Y., Aleshin, G. Y., Plakhova, T. V., Zubenko, A. D., Shchukina, A. A., Fedorova, O. A., Averin, A. A., Belova, E. V., Bazarkina, E. F., Kvashnina, K. O., Kalmykov, S. N., Khabirova, S. Y., Aleshin, G. Y., Plakhova, T. V., Zubenko, A. D., Shchukina, A. A., Fedorova, O. A., Averin, A. A., Belova, E. V., Bazarkina, E. F., Kvashnina, K. O., and Kalmykov, S. N.
- Abstract
This communication is one of the first attempts to assess CeO2 nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with 207Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals
- Published
- 2022